美股異動 | 塔吉特(TGT.US)跌超14% Q3利潤腰斬且遜預期 下調Q4業績指引
格隆匯11月16日丨塔吉特(TGT.US)跌超14%,報152.65美元。該公司今日公佈,第三季度營收同比增長3.4%至265.2億美元,高於預期的263.8億美元;淨利潤下降約一半至7.12億美元,合每股1.54美元,低於預期的2.13美元。 第三季度,公司營業利潤率為3.9%,而其目標為6%。 首席財務官Michael Fiddelke表示:“展望未來,我們預計這種充滿挑戰的環境將持續到假日季之後,直至2023年。”該公司週三還表示,計劃在未來三年內削減高達30億美元的總成本,並預計第四季度營收將出現個位數的降幅。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.